Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 567

1.

Alzheimer's Disease and Neurotransmission Gene Variants: Focus on Their Effects on Psychiatric Comorbidities and Inflammatory Parameters.

Porcelli S, Calabrò M, Crisafulli C, Politis A, Liappas I, Albani D, Raimondi I, Forloni G, Benedetti F, Papadimitriou GN, Serretti A.

Neuropsychobiology. 2019 May 16:1-7. doi: 10.1159/000497164. [Epub ahead of print]

PMID:
31096213
2.

FKBP5 Gene Variants May Modulate Depressive Features in Bipolar Disorder.

Calabrò M, Crisafulli C, Di Nicola M, Colombo R, Janiri L, Serretti A.

Neuropsychobiology. 2019 May 9:1-8. doi: 10.1159/000499976. [Epub ahead of print]

PMID:
31071710
3.

Major depression and comorbid diabetes - Findings from the European Group for the Study of Resistant Depression.

Fugger G, Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Frey R, Kasper S.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 May 2:109638. doi: 10.1016/j.pnpbp.2019.109638. [Epub ahead of print]

PMID:
31054944
4.

Genome-wide association study identifies 30 loci associated with bipolar disorder.

Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, Mattheisen M, Wang Y, Coleman JRI, Gaspar HA, de Leeuw CA, Steinberg S, Pavlides JMW, Trzaskowski M, Byrne EM, Pers TH, Holmans PA, Richards AL, Abbott L, Agerbo E, Akil H, Albani D, Alliey-Rodriguez N, Als TD, Anjorin A, Antilla V, Awasthi S, Badner JA, Bækvad-Hansen M, Barchas JD, Bass N, Bauer M, Belliveau R, Bergen SE, Pedersen CB, Bøen E, Boks MP, Boocock J, Budde M, Bunney W, Burmeister M, Bybjerg-Grauholm J, Byerley W, Casas M, Cerrato F, Cervantes P, Chambert K, Charney AW, Chen D, Churchhouse C, Clarke TK, Coryell W, Craig DW, Cruceanu C, Curtis D, Czerski PM, Dale AM, de Jong S, Degenhardt F, Del-Favero J, DePaulo JR, Djurovic S, Dobbyn AL, Dumont A, Elvsåshagen T, Escott-Price V, Fan CC, Fischer SB, Flickinger M, Foroud TM, Forty L, Frank J, Fraser C, Freimer NB, Frisén L, Gade K, Gage D, Garnham J, Giambartolomei C, Pedersen MG, Goldstein J, Gordon SD, Gordon-Smith K, Green EK, Green MJ, Greenwood TA, Grove J, Guan W, Guzman-Parra J, Hamshere ML, Hautzinger M, Heilbronner U, Herms S, Hipolito M, Hoffmann P, Holland D, Huckins L, Jamain S, Johnson JS, Juréus A, Kandaswamy R, Karlsson R, Kennedy JL, Kittel-Schneider S, Knowles JA, Kogevinas M, Koller AC, Kupka R, Lavebratt C, Lawrence J, Lawson WB, Leber M, Lee PH, Levy SE, Li JZ, Liu C, Lucae S, Maaser A, MacIntyre DJ, Mahon PB, Maier W, Martinsson L, McCarroll S, McGuffin P, McInnis MG, McKay JD, Medeiros H, Medland SE, Meng F, Milani L, Montgomery GW, Morris DW, Mühleisen TW, Mullins N, Nguyen H, Nievergelt CM, Adolfsson AN, Nwulia EA, O'Donovan C, Loohuis LMO, Ori APS, Oruc L, Ösby U, Perlis RH, Perry A, Pfennig A, Potash JB, Purcell SM, Regeer EJ, Reif A, Reinbold CS, Rice JP, Rivas F, Rivera M, Roussos P, Ruderfer DM, Ryu E, Sánchez-Mora C, Schatzberg AF, Scheftner WA, Schork NJ, Shannon Weickert C, Shehktman T, Shilling PD, Sigurdsson E, Slaney C, Smeland OB, Sobell JL, Søholm Hansen C, Spijker AT, St Clair D, Steffens M, Strauss JS, Streit F, Strohmaier J, Szelinger S, Thompson RC, Thorgeirsson TE, Treutlein J, Vedder H, Wang W, Watson SJ, Weickert TW, Witt SH, Xi S, Xu W, Young AH, Zandi P, Zhang P, Zöllner S; eQTLGen Consortium; BIOS Consortium, Adolfsson R, Agartz I, Alda M, Backlund L, Baune BT, Bellivier F, Berrettini WH, Biernacka JM, Blackwood DHR, Boehnke M, Børglum AD, Corvin A, Craddock N, Daly MJ, Dannlowski U, Esko T, Etain B, Frye M, Fullerton JM, Gershon ES, Gill M, Goes F, Grigoroiu-Serbanescu M, Hauser J, Hougaard DM, Hultman CM, Jones I, Jones LA, Kahn RS, Kirov G, Landén M, Leboyer M, Lewis CM, Li QS, Lissowska J, Martin NG, Mayoral F, McElroy SL, McIntosh AM, McMahon FJ, Melle I, Metspalu A, Mitchell PB, Morken G, Mors O, Mortensen PB, Müller-Myhsok B, Myers RM, Neale BM, Nimgaonkar V, Nordentoft M, Nöthen MM, O'Donovan MC, Oedegaard KJ, Owen MJ, Paciga SA, Pato C, Pato MT, Posthuma D, Ramos-Quiroga JA, Ribasés M, Rietschel M, Rouleau GA, Schalling M, Schofield PR, Schulze TG, Serretti A, Smoller JW, Stefansson H, Stefansson K, Stordal E, Sullivan PF, Turecki G, Vaaler AE, Vieta E, Vincent JB, Werge T, Nurnberger JI, Wray NR, Di Florio A, Edenberg HJ, Cichon S, Ophoff RA, Scott LJ, Andreassen OA, Kelsoe J, Sklar P; Bipolar Disorder Working Group of the Psychiatric Genomics Consortium.

Nat Genet. 2019 May;51(5):793-803. doi: 10.1038/s41588-019-0397-8. Epub 2019 May 1.

PMID:
31043756
5.

Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter study.

Fugger G, Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Frey R, Kasper S.

Eur Neuropsychopharmacol. 2019 Apr 18. pii: S0924-977X(19)30193-2. doi: 10.1016/j.euroneuro.2019.03.005. [Epub ahead of print]

PMID:
31006562
6.

Temperament and character influence on depression treatment outcome.

Balestri M, Porcelli S, Souery D, Kasper S, Dikeos D, Ferentinos P, Papadimitriou GN, Rujescu D, Martinotti G, Nicola MD, Janiri L, Caletti E, Mandolini GM, Pigoni A, Paoli RA, Lazzaretti M, Brambilla P, Sala M, Abbiati V, Bellani M, Perlini C, Rossetti MG, Piccin S, Bonivento C, Fabbro D, Damante G, Ferrari C, Rossi R, Pedrini L, Benedetti F, Montgomery S, Zohar J, Mendlewicz J, Serretti A.

J Affect Disord. 2019 Jun 1;252:464-474. doi: 10.1016/j.jad.2019.04.031. Epub 2019 Apr 9.

PMID:
31005789
7.

The brief assessment of cognition in affective disorders: Normative data for the Italian population.

Rossetti MG, Bonivento C, Garzitto M, Caletti E, Perlini C, Piccin S, Lazzaretti M, Marinelli V, Sala M, Abbiati V, Rossi R, Lanfredi M, Serretti A, Porcelli S, Bellani M, Brambilla P; GecoBip Group.

J Affect Disord. 2019 Jun 1;252:245-252. doi: 10.1016/j.jad.2019.04.063. Epub 2019 Apr 8.

PMID:
30991252
8.

Attrition in treatment-resistant depression: predictors and clinical impact.

Olgiati P, Serretti A, Souery D, Kasper S, Kraus C, Montgomery S, Zohar J, Mendlewicz J.

Int Clin Psychopharmacol. 2019 Apr 2. doi: 10.1097/YIC.0000000000000261. [Epub ahead of print]

PMID:
30946169
9.

Personalized and precision medicine as informants for treatment management of bipolar disorder.

Perugi G, De Rossi P, Fagiolini A, Girardi P, Maina G, Sani G, Serretti A.

Int Clin Psychopharmacol. 2019 Mar 25. doi: 10.1097/YIC.0000000000000260. [Epub ahead of print]

PMID:
30932919
10.

Genetic Overlap Between Alzheimer's Disease and Bipolar Disorder Implicates the MARK2 and VAC14 Genes.

Drange OK, Smeland OB, Shadrin AA, Finseth PI, Witoelar A, Frei O; Psychiatric Genomics Consortium Bipolar Disorder Working Group, Wang Y, Hassani S, Djurovic S, Dale AM, Andreassen OA.

Front Neurosci. 2019 Mar 13;13:220. doi: 10.3389/fnins.2019.00220. eCollection 2019.

11.

Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression.

Fanelli G, Benedetti F, Wang SM, Lee SJ, Jun TY, Masand PS, Patkar AA, Han C, Serretti A, Pae CU, Fabbri C.

J Affect Disord. 2019 Apr 15;249:410-417. doi: 10.1016/j.jad.2019.02.042. Epub 2019 Feb 13.

PMID:
30826620
12.

Predominant polarity in bipolar disorder patients: The COPE bipolar sample.

Sentissi O, Popovic D, Moeglin C, Stukalin YB, Mosheva M, Vieta E, Serretti A, Souery D.

J Affect Disord. 2019 May 1;250:43-50. doi: 10.1016/j.jad.2019.02.053. Epub 2019 Feb 20.

PMID:
30826493
13.

High occupational level is associated with poor response to the treatment of depression: A replication study.

Mandelli L, Serretti A, Souery D, Mendlewicz J, Kasper S, Montgomery S, Zohar J.

Eur Neuropsychopharmacol. 2019 Mar;29(3):349-355. doi: 10.1016/j.euroneuro.2019.01.107. Epub 2019 Jan 28.

PMID:
30704794
14.

Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression.

Dold M, Bartova L, Kautzky A, Porcelli S, Montgomery S, Zohar J, Mendlewicz J, Souery D, Serretti A, Kasper S.

J Clin Psychiatry. 2019 Jan 15;80(1). pii: 17m12090. doi: 10.4088/JCP.17m12090.

PMID:
30677267
15.

Duloxetine plasma level and antidepressant response.

De Donatis D, Florio V, Porcelli S, Saria A, Mercolini L, Serretti A, Conca A.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:127-132. doi: 10.1016/j.pnpbp.2019.01.001. Epub 2019 Jan 3.

PMID:
30611837
16.

Corrected QT Interval Prolongation in Psychopharmacological Treatment and Its Modulation by Genetic Variation.

Corponi F, Fabbri C, Boriani G, Diemberger I, Albani D, Forloni G, Serretti A.

Neuropsychobiology. 2019;77(2):67-72. doi: 10.1159/000493400. Epub 2018 Dec 13.

PMID:
30544110
17.

Biallelic variants in FBXL3 cause intellectual disability, delayed motor development and short stature.

Ansar M, Paracha SA, Serretti A, Sarwar MT, Khan J, Ranza E, Falconnet E, Iwaszkiewicz J, Shah SF, Qaisar AA, Santoni FA, Zoete V, Megarbane A, Ahmed J, Colombo R, Makrythanasis P, Antonarakis SE.

Hum Mol Genet. 2018 Nov 26. doi: 10.1093/hmg/ddy406. [Epub ahead of print]

PMID:
30481285
18.

Quantitative neurosymptomatics: Linking quantitative biology to neuropsychiatry.

Kas MJ, Serretti A, Marston H.

Neurosci Biobehav Rev. 2019 Feb;97:1-2. doi: 10.1016/j.neubiorev.2018.11.013. Epub 2018 Nov 23. No abstract available.

PMID:
30476505
19.

Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples.

Fabbri C, Kasper S, Kautzky A, Bartova L, Dold M, Zohar J, Souery D, Montgomery S, Albani D, Raimondi I, Dikeos D, Rujescu D, Uher R, Lewis CM, Mendlewicz J, Serretti A.

Br J Psychiatry. 2019 Jan;214(1):36-41. doi: 10.1192/bjp.2018.256. Epub 2018 Nov 23.

PMID:
30468137
20.

A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial.

Han C, Wang SM, Bahk WM, Lee SJ, Patkar AA, Masand PS, Mandelli L, Pae CU, Serretti A.

Clin Psychopharmacol Neurosci. 2018 Nov 30;16(4):469-480. doi: 10.9758/cpn.2018.16.4.469.

Supplemental Content

Loading ...
Support Center